transplants

New studies proposed using stem cells to make long-lasting lung grafts.

The organoids could one day be used to treat brain injuries in humans. 

How single-cell secretomic analysis revealed the role of TEMRA CD8⁺ T cells in kidney transplant rejection.

The human cells, engineered to respond to blue light, influenced rat behavior when stimulated.

Researchers use organoid cultures in unique ways to study health and disease.

Researchers are revealing the complexity of the microbial community living on the body—and paving the way for new bacteria-targeting treatments for acne and other dermatological conditions.

The procedure, performed last Friday, is a milestone in a long effort to boost the number of organs available for safe transplantation.

As the year draws to a close, we look back on researchers we bid farewell to, and the contributions they made to their respective fields.

Guidelines for maintaining human cells grown ex vivo

The achievement bolsters hopes that nonhuman animals could be used to remedy the shortage of transplantable organs.

Explore tissue-specific protocols for growing organoids from primary tissue or stem cells.

Scientists are banking various samples from recipients of donated uteruses to learn all they can about the biology of the organ, and about transplantation more generally.

With human research trials resulting in dozens of successful deliveries in the US and abroad, doctors move toward offering the surgery clinically, while working to learn all they can about uterine and transplant biology from the still-rare procedure.

Her work led to more predictable outcomes for kidney transplants.

The National Academies’ report touches on ethical issues raised by new technologies such as brain organoids and human-animal chimeras, and suggests that current regulatory oversight is sufficient.

Researchers determined that when introduced into damaged mouse or donated human livers, these lab-grown tissues could integrate into bile ducts and function normally.

New twists to an old technique reveal a better understanding of disease pathology and new therapeutic avenues.

Infusions of donor T cells to fight the cancer often fail, but sodium bicarbonate can counter lactic acid produced by leukemia cells, potentially improving remission rates in mice and humans.

A proof-of-concept study uses a strategy similar to the way tumors evade immune detection. The new limbs survive for more than 200 days.